category
news
release
media
information
EditForce Participated in Rett Syndrome Genetic Medicines Summit
RELOCATION OF HEADQUARTERS
COMPLETION OF FUND RAISING THROUGH THIRD-PARTY ALLOTMENT OF SHARES
ADOPTION OF AMED STRENGTHENING PROGRAM FOR PHARMACEUTICAL STARTUP ECOSYSTEM
FUND RAISING THROUGH THIRD-PARTY ALLOTMENT OF SHARES
EditForce achieved establishment of a high-throughput construction method for PPR protein gene and its application for splicing control in human cells
EditForce Realizes RNA-editing Technology of “U-to-C” in Human Cells
EDITFORCE AND MITSUBISHI TANABE PHARMA ENTER INTO LICENSE AGREEMENT
Announcement of Capital Reduction
EditForce completed fund raising by third-party allotment and AMED adopts our program
archive
All
Feel free to contact us when you have any questions or concerns.
